Cook, Madison K.
Kelly, Katherine A.
Perche, Patrick O.
Singh, Rohan
Richardson, Irma
Feldman, Steven R.
Article History
Received: 16 June 2022
Revised: 16 June 2022
Accepted: 9 January 2023
First Online: 18 January 2023
Declarations
:
: The authors declare the following potential conflicts. Dr. Steven Feldman has received research, speaking and/or consulting support from a variety of companies including Galderma, GSK/Stiefel, Almirall, Leo Pharma, Baxter, Boeringer Ingelheim, Mylan, Celgene, Pfizer, Valeant, Taro, Abbvie, Cosmederm, Anacor, Astellas, Janssen, Lilly, Merck, Merz, Novartis, Regeneron, Sanofi, Novan, Parion, Qurient, National Biological Corporation, Caremark, Advance Medical, Sun Pharma, Suncare Research, Informa, UpToDate and National Psoriasis Foundation. He is founder and majority owner of ExternalRef removed and founder and part owner of Causa Research, a company dedicated to enhancing patients’ adherence to treatment. Madison K. Cook, Katherine A. Kelly, Patrick O. Perche, Rohan Singh, and Irma Richardson have no conflicts of interest to report.
: Reviewed and approved by Wake Forest IRB; approval # IRB00062694.